1.77
price down icon1.67%   -0.03
after-market Handel nachbörslich: 1.77
loading

Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.6485
- 4.5726 3.1421 4.1089
Operating Income/Loss
-2.6485
- -4.5726 -3.1421 -4.1089
Income/Loss From Continuing Operations Before Tax
43.10%
-2.9751
-5.2289 -4.5324 -3.069 -4.0153
Income/Loss From Continuing Operations After Tax
43.10%
-2.9751
-5.2289 -4.5324 -3.069 -4.0153
Net Income/Loss
43.10%
-2.9751
-5.2289 -4.5324 -3.069 -4.0153
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.997
- 14.10 9.5104 8.5439
Diluted Average Shares
0.997
- 14.10 9.5104 8.5439
Basic Earnings Per Share
-2.98
- -0.32 -0.32 -0.47
Diluted Earnings Per Share
-2.98
- -0.32 -0.32 -0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):